Results 131 to 140 of about 7,478 (186)

Pharmacokinetic Optimisation of Histamine H1-Receptor Antagonist Therapy

Clinical Pharmacokinetics, 1991
Second-generation, relatively nonsedating histamine H1-receptor antagonists (H1-RA) are extensively used worldwide for the symptomatic treatment of allergic rhinoconjunctivitis and chronic urticaria. Information about the pharmacokinetics and pharmacodynamics of these medications, while still incomplete, is now sufficient to permit optimisation of ...
F. Estelle, R. Simons, Keith J. Simons
openaire   +2 more sources

The effect of H1 and H2 histamine antagonists on symptomatic dermographism

British Journal of Dermatology, 1979
In ten patients suffering from symptomatic dermographism the combined administration of chlorpheniramine + cimetidine produced a greater reduction in the weal and flare response provoked by a standardized scratch than the administration of chlorpheniramine alone. There was a statistically significant improvement in the overall assessment of the patient'
C N, Matthews, J M, Boss, R P, Warin, F, Storari   +3 more
openaire   +2 more sources

[H1 histamine antagonists].

Revue medicale de Bruxelles, 2003
Histamine is an important mediator for early phase allergic reactions that are involved in atopic diseases, mediated by specific IgE antibodies. After allergenic contact, its liberation induces unpleasant symptoms like itching, several manifestations as local vasodilatation, bronchoconstriction, mucus hypersecretion.
J, Duchateau, M, Heenen, J, Sternon
openaire   +1 more source

Inhibition by Cations of Antagonist Binding to Histamine H1-Receptors

1991
The binding of the quaternary radioligand [3H] QMDP to the histamine H1-receptor was inhibited by a series of mono- and di-valent cations. The order of potency was Hg2+ greater than Cd2+ greater than Zn2+ greater than Ni2+ greater than Co2+ greater than Mn2+ greater than Ca2+ greater than Mg2+ greater than Li+ = Na+ greater than K+ greater than Cs ...
J M, Treherne, J S, Stern, W J, Flack, J M, Young   +3 more
openaire   +2 more sources

Interactions of Histamine H1-Receptor Agonists and Antagonists with the Human Histamine H4-Receptor

Molecular Pharmacology, 2009
The human histamine H(4)-receptor (hH(4)R) possesses high constitutive activity and, like the human H(1)-receptor (hH(1)R), is involved in the pathogenesis of type-I allergic reactions. The study aims were to explore the value of dual H(1)/H(4)R antagonists as antiallergy drugs and to address the question of whether H(1)R ligands bind to hH(4)R.
Karl-Friedrich, Deml, Silke, Beermann, Detlef, Neumann, Andrea, Strasser, Roland, Seifert   +4 more
openaire   +2 more sources

Histamine H1-receptor antagonist activity assessed in conscious dogs

Journal of Pharmacological Methods, 1987
A simple, minimally invasive technique is described which allows assessment of histamine H1-receptor antagonist activity in conscious dogs. The technique is based on the inhibition of the tachycardia caused by intravenous administration of the H1-receptor agonist, 2-pyridylethylamine.
A, Wright, P, Raval, R J, Eden, D A, Owen   +3 more
openaire   +2 more sources

Diphenylpyraline, a histamine H1 receptor antagonist, has psychostimulant properties

European Journal of Pharmacology, 2005
Diphenylpyraline hydrochloride (DPP) is used clinically as an antihistamine drug, but its neurobiological effects are not completely understood. Voltammetry and microdialysis were used to investigate potential actions of DPP on the dopamine system. Voltammetric monitoring of dopamine signals in mouse nucleus accumbens slices showed that DPP (10 microM)
Gennady B, Lapa, Tiffany A, Mathews, Jill, Harp, Evgeny A, Budygin, Sara R, Jones   +4 more
openaire   +2 more sources

Clinical comparison of histamine H1–receptor antagonist drugs

Journal of Allergy and Clinical Immunology, 1996
Nearly 40 million Americans have symptoms of upper respiratory allergies, making antihistamines among the most frequently used pharmacologic agents. Although there are mediators of allergic symptoms in addition to histamine, therapy for allergic rhinitis and urticaria has focused upon the use of antihistamines.
openaire   +2 more sources

Trifluoperazine inhibits phosphoinositide hydrolysis as a histamine H1-receptor antagonist

European Journal of Pharmacology: Molecular Pharmacology, 1991
In human astrocytoma cells (1321N1), trifluoperazine potently inhibited histamine-induced phosphoinositide hydrolysis, while it slightly inhibited carbachol-induced phosphoinositide hydrolysis. Trifluoperazine as well as diphenhydramine inhibited [3H]mepyramine binding in astrocytoma cell membranes with Ki values of 0.052 microM and 0.005 microM ...
N, Nakahata, H, Ishimoto, A, Takahashi, K, Ohmori, M, Kurita   +4 more
openaire   +2 more sources

Opiate and H1 antagonist effects on histamine induced pruritus and alloknesis

Pain, 1997
Itching is a well known side-effect of opiate therapy. To gain insight into the possible contribution of opiate receptors to itching we compared the antipruritic effect of naltrexone (Nemexin), an opiate antagonist, to an H1-receptor antagonist and to placebo.
G, Heyer, M, Dotzer, L T, Diepgen, O H, Handwerker   +3 more
openaire   +2 more sources